KAITLYN RENARD: Open Payments
NPI 1952916827 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 41 payments from 21 companies in 2025. Trend: 2023 $371 · 2024 $899 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $163 |
| Novo Nordisk Inc | 13 | $145 |
| Stryker Corporation | 2 | $57 |
| Astellas Pharma US Inc | 2 | $51 |
| Corium, LLC | 3 | $47 |
| Lundbeck LLC | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Baxter Healthcare | 1 | $23 |
| Verona Pharma, Inc. | 1 | $21 |
Products named: AIRSUPRA, CLOTTRIEVER BOLD CATHETER, Ozempic, Veozah, REXULTI, Azstarys, Wegovy, JARDIANCE.
Industry payments across KY — which companies pay providers there.
